• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征:长期预后与医患互动

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction.

作者信息

Owens D M, Nelson D K, Talley N J

机构信息

Mayo Clinic and Foundation, Rochester, Minnesota.

出版信息

Ann Intern Med. 1995 Jan 15;122(2):107-12. doi: 10.7326/0003-4819-122-2-199501150-00005.

DOI:10.7326/0003-4819-122-2-199501150-00005
PMID:7992984
Abstract

OBJECTIVE

To evaluate the long-term course and prognosis associated with the irritable bowel syndrome (IBS) and to determine the influence of an effective physician-patient relationship on subsequent health care use.

DESIGN

Prospective review of medical records.

SETTING

Tertiary referral center.

PATIENTS

112 consecutive Olmsted County, Minnesota, residents who were first diagnosed with IBS at the Mayo Clinic during the period 1961-1963.

RESULTS

The median follow-up was 29 years (range, 1 to 32 years) and patients made a median of 2 return visits for IBS-related symptoms (range, 0 to 12 visits). In addition to abdominal pain, diarrhea (reported by 50% of patients) was the predominant bowel symptom at diagnosis. Organic gastrointestinal disease occurred in 10 patients a median of 15 years after diagnosis of IBS. Survival in patients with IBS did not differ from expected survival (27 deaths; median survival > 30 years after initial diagnosis). A positive physician-patient interaction, defined a priori using objective criteria in the written record, was associated with fewer return visits for IBS. Of the eight variables examined, notations in the medical record about psychosocial history, precipitating factors, and discussion of diagnosis and treatment with patients were associated with fewer return visits for IBS-related symptoms.

CONCLUSIONS

When diagnosed according to current criteria, IBS is associated with a good prognosis and the diagnosis is unlikely to be changed to that of an organic disease during follow-up. A positive physician-patient interaction may be related to reduced use of ambulatory health services by patients with IBS.

摘要

目的

评估肠易激综合征(IBS)的长期病程及预后,并确定有效的医患关系对后续医疗保健利用的影响。

设计

对病历进行前瞻性回顾。

地点

三级转诊中心。

患者

1961年至1963年期间在梅奥诊所首次被诊断为IBS的明尼苏达州奥尔姆斯特德县的112名连续居民。

结果

中位随访时间为29年(范围1至32年),患者因IBS相关症状进行复诊的中位次数为2次(范围0至12次)。除腹痛外,腹泻(50%的患者报告有此症状)是诊断时主要的肠道症状。10例患者在IBS诊断后中位15年出现了器质性胃肠疾病。IBS患者的生存率与预期生存率无差异(27例死亡;初次诊断后中位生存时间>30年)。根据书面记录中预先设定的客观标准定义的积极医患互动与IBS复诊次数减少相关。在所检查的八个变量中,病历中关于心理社会病史、诱发因素以及与患者讨论诊断和治疗的记录与IBS相关症状复诊次数减少有关。

结论

按照当前标准诊断时,IBS预后良好,随访期间诊断不太可能转变为器质性疾病。积极的医患互动可能与IBS患者减少使用门诊医疗服务有关。

相似文献

1
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction.肠易激综合征:长期预后与医患互动
Ann Intern Med. 1995 Jan 15;122(2):107-12. doi: 10.7326/0003-4819-122-2-199501150-00005.
2
[Patient-doctor relationship in the irritable bowel syndrome. Results of a French prospective study on the influence of the functional origin of the complaints].[肠易激综合征中的医患关系。一项关于主诉功能起源影响的法国前瞻性研究结果]
Gastroenterol Clin Biol. 2002 Dec;26(12):1125-33.
3
Diagnosis and care of irritable bowel syndrome in a community-based population.社区人群中肠易激综合征的诊断与护理
Am J Manag Care. 2001 Jun;7(6):585-92.
4
Diagnosing irritable bowel syndrome.诊断肠易激综合征。
Rev Gastroenterol Disord. 2003;3 Suppl 2:S12-7.
5
[A consecutive study of patients with irritable bowel disease in two tertiary referral centers].[在两个三级转诊中心对肠易激综合征患者进行的一项连续性研究]
Psychother Psychosom Med Psychol. 2001 Jul;51(7):267-75. doi: 10.1055/s-2001-15625.
6
Irritable bowel syndrome: update on pathogenesis and management.肠易激综合征:发病机制与管理的最新进展
Med Princ Pract. 2002 Jan-Mar;11(1):2-17. doi: 10.1159/000048654.
7
Symptom duration in patients with irritable bowel syndrome.肠易激综合征患者的症状持续时间。
Am J Gastroenterol. 1996 May;91(5):898-905.
8
Defining and diagnosing irritable bowel syndrome.肠易激综合征的定义与诊断
Am J Manag Care. 2001 Jul;7(8 Suppl):S246-51.
9
Patient knowledge and educational needs in irritable bowel syndrome.
Eur J Gastroenterol Hepatol. 2000 Jan;12(1):39-43. doi: 10.1097/00042737-200012010-00008.
10
Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?中重度肠易激综合征患者的腹痛与腹部不适有区别吗?
Am J Gastroenterol. 2002 Dec;97(12):3131-8. doi: 10.1111/j.1572-0241.2002.07110.x.

引用本文的文献

1
Differences in medical care satisfaction of patients with "functional" vs "organic" esophageal diseases, Italian validation of the PPRS SF questionnaire.“功能性”与“器质性”食管疾病患者医疗护理满意度的差异:PPRS SF问卷的意大利语验证
Sci Rep. 2025 Mar 20;15(1):9569. doi: 10.1038/s41598-025-93576-3.
2
Update in diagnosis and management of irritable bowel syndrome.肠易激综合征诊断与管理的最新进展
Tzu Chi Med J. 2023 Sep 22;35(4):306-311. doi: 10.4103/tcmj.tcmj_104_23. eCollection 2023 Oct-Dec.
3
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome-wide association study.
肠易激综合征患者的合并症、生物标志物和病因特异性死亡率:一项表型全基因组关联研究。
United European Gastroenterol J. 2023 Jun;11(5):458-470. doi: 10.1002/ueg2.12397. Epub 2023 May 7.
4
Best management of irritable bowel syndrome.肠易激综合征的最佳管理
Frontline Gastroenterol. 2020 May 28;12(4):303-315. doi: 10.1136/flgastro-2019-101298. eCollection 2021.
5
Central Sensitization Symptom Severity and Patient-Provider Relationships in a Community Setting.社区环境中的中枢敏化症状严重程度与医患关系。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211031767. doi: 10.1177/21501327211031767.
6
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.国际视角下炎症性肠病的管理:IBD GAPPS 调查中患者和医生的意见差异和相似性。
Inflamm Bowel Dis. 2021 Nov 15;27(12):1942-1953. doi: 10.1093/ibd/izab006.
7
Preliminary development and validation of the Patient-Physician Relationship Scale for physicians for disorders of gut-brain interaction.用于肠脑相互作用障碍的医患关系量表的初步开发和验证。
Neurogastroenterol Motil. 2021 Feb;33(2):e13976. doi: 10.1111/nmo.13976. Epub 2020 Sep 1.
8
Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study.肠易激综合征患者的死亡风险:一项全国前瞻性队列研究的结果。
Am J Gastroenterol. 2020 May;115(5):746-755. doi: 10.14309/ajg.0000000000000573.
9
Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.评估肠易激综合征便秘型和慢性特发性便秘患者何时以及为何停止慢性治疗。
Am J Gastroenterol. 2020 Apr;115(4):596-602. doi: 10.14309/ajg.0000000000000530.
10
Identification of patients with moderate medically unexplained physical symptoms in primary care with a five years follow-up.识别初级保健中具有中度医学无法解释的躯体症状的患者,进行为期五年的随访。
BMC Fam Pract. 2019 May 21;20(1):66. doi: 10.1186/s12875-019-0950-7.